Premature immunosenescence: A pathogenetic factor in Alzheimer's disease?;Vorzeitige Immunalterung: ein pathogenetischer Faktor bei Alzheimer-Demenz?

Nervenarzt

Volumn 81, Issue 7, 2010, Pages 837-843

  Richartz Salzburger, E ^a   Stransky, E ^a   Laske, C ^a   Kohler N ^a  

^a UNIVERSITY HOSPITAL TÜBINGEN   (Germany)

Author keywords

Alzheimer's disease; Amyloid; Immunosenescence; Vaccination

Indexed keywords

IMMUNOLOGIC AGENT;

AGING; ALZHEIMER DISEASE; HUMAN; IMMUNOPATHOGENESIS; IMMUNOTHERAPY; INFLAMMATION; REVIEW; RISK FACTOR; VACCINATION;

ALZHEIMER DISEASE; HUMANS; IMMUNOTHERAPY; INFLAMMATION;

EID: 77955563723     PISSN: 00282804     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00115-009-2918-7     Document Type: Review

References (36)

1. Akiyama H, Barger S, Barnum S et al (2000) Inflammation and Alzheimer's disease. Neuroinflammation working group. Neurobiol Aging 21:383-421
2. Antonaci S, Garofalo AR, Chicco C et al (1990) Senile dementia, Alzheimer type: a distinct entity in the immunosenescence? J Clin Lab Anal 4:16-21
3. Bamberger ME, Landreth GE (2001) Microglial interaction with beta-amyloid: implications for the pathogenesis of Alzheimer's disease. Microsc Res Tech 54:59-70
4. Blasko I, Grubeck-Loebenstein B (2003) Role of the immune system in the pathogenesis, prevention and treatment of Alzheimer's disease. Drugs Aging 20:101-113
5. Dean R, Bell RD, Sagare A, Zklokovic BV (2009) Clearance of amyloid-beta peptide across the blood-brain barrier: implication for therapies in Alzheimer's disease. CNS Neurol Disord Drug Targets 8(1):16-30
6. DeMattos RB, Bales KR, Cummins DJ et al (2001) Peripheral anti-A-beta antibody alters CNS and plasma A beta clearance and decreases brain A beta burden in a mouse model of Alzheimer's disease. Proc Natl Acad Sci U S A 19:8850-8855
7. De la Monte SM, Luong T, Neely TR et al (2000) Mitochondrial DNA damage as a mechanism of cell loss in Alzheimer disease. Lab Invest 80:1323-1335
8. Du Y, Dodel R, Hampel H (2001) Reduced levels of amyloid beta-peptide antibody in Alzheimer disease. Neurology 57:801-805
9. Effros RB (1998) Replicative senescence in the immune system: Impact of the Hayflick limit on T cell function in the elderly. Am J Hum Genet 62:1003-1007
10. Fiala M, Lin J, Ringman J et al (2005) Ineffective phagocytosis of amyloid-β by macrophages of Alzheimer's disease patients. J Alzheimers Dis 7:221-232
11. Franceschi C, Monti D, Scarfi MR et al (1992) Genomic instability and aging. Studies in centenarians (successful aging) and in patients with Down's syndrome (accelerated aging). Ann N Y Acad Sci 663:4-16
12. Giunta B, Fernandez F, Nikolic WV et al (2008) Inflammaging as a prodrome to Alzheimer's disease. J Neuroinflammation 11:51
13. Grimmer T, Perneczky R, Kurz A (2008) Aktueller Stand der Immuntherapie bei Alzheimer-Krankheit. Nervenarzt 79:822-845
14. Guayerbas N, Puerto M, Victor VM et al (2002) Leukocyte function and life span in a murine model of premature immunosenescence. Exp Gerontol 37:249-256
15. Hardy J, Selkoe DJ (2002) The amyloid hypothesis of Alzheimer's disease: Progress and problems on the road to therapeutics. Science 297:353-356
16. Jenner E (1798) An inquiry into the causes and effects of the variolae vaccine, or cow-pox. In: The three original publications on v ccination against smallpox. Vol. XXXVIII, Part 4 (2001). Collier PF, Son Bartleby.com, The Harvard Classics, New York, pp 1909-1014
17. Kalaria RN (1993) The immunopathology of Alzheimer's disease and some related disorders. Brain Pathol 3:333-347
18. Lee M, Sparatore A, Del Soldato P et al (2009) Hydrogen sulfide-releasing NSAIDs attenuate neuroinflammation induced by microglial and astrocytic activation. Glia 18: Epub ahead of print
19. Mancuso M, Orsucci D, Siciliano G, Murri L (2008) Mitochondria, mitochondrial DNA and Alzheimer's disease. What comes first? Curr Alzheimer Res 5:457-468
20. McGeer PL, McGeer EG (2001) Inflammation, autotoxicity and Alzheimer's disease. Neurobiol Aging 22:799-809
21. Nandy K (1977) Immune reactions in aging brain and senile dementia. In: Nandy K, Sherwin I (eds) The aging brain and senile dementia. Plenum, New York, pp 181-196
22. Panossian LA, Porter VR, Valenzuela HF et al (2003) Telomere shortening in T cells correlates with Alzheimer disease status. Neurobiol Aging 24:77-84
23. Park E, Alberti J, Mehta P et al (2000) Partial impaired immune functions in peripheral blood leukocytes from aged men with Down's syndrome. Clin Immunol 95:62-69
24. Popovic M, Caballero-Bleda M, Puelles L, Popovic N (1998) Importance of immunological and inflammatory processes in the pathogenesis and therapy of Alzheimer's disease. Int J Neurosci 95:203-236
25. Richartz E, Klein R, Stransky E et al (2004) Autoantibody reactivity in serum and cerebrospinal fluid of patients with Alzheimer's disease. Neurol Psychiat Brain Res 11:145-148
26. Richartz E, Batra A, Stransky E et al (2005) Diminished production of proinflammatory cytokines in patients with Alzheimer's disease. Dement Geriatr Cogn Disord 19:184-188
27. Richartz E, Batra A, Stransky E et al (2007) Altered lymphoycyte distribution in Alzheimer's disease. J Psychiatr Res 41:1-8
28. Richartz-Salzburger E (2008) Psychoimmunologische Forschung bei Alzheimer-Demenz. Monographien aus dem Gesamtgebiete der Psychiatrie. Bd 114. Steinkopff, Darmstadt
29. Schenk D, Barbour R, Dunn W et al (1999) Immunization with amyloid-beta attenuates Alzheimer-disease-like pathology in the PDAPP mouse. Nature 400:173-177
30. Singh VK, Fudenberg HH, Brown FR (1986-1987) Immunologic dysfunction: Simultaneous study of Alzheimer's and older Down's patients. Mech Ageing Dev 37:257-264
31. Singh VK (1997) Neuroautoimmunity: Pathogenetic implications for Alzheimer's disease. Gerontology 43:79-94
32. Solomon B (2007) Antibody-mediated immunotherapy for Alzheimer's disease. Curr Opin Investig Drugs 8:519-524
33. Streit WJ (2002) Microglia as neuroprotective, immunocompetent cells of the CNS. Glia 40:133-139
34. Tan ZS, Beiser AS, Vasan RS et al (2007) Inflammatory markers and the risk of Alzheimer disease: the framingham study. Neurology 68:1902-1908
35. Wekerle H, Linington C, Lassmann H, Meyermann R (1986) Cellular immune reactivity within the CNS. Trends Neurosci 9:271-277
36. Zhang J, Kong Q, Zhang Z et al (2003) Telomere dysfunction of lymphocytes in patients with Alzheimer's disease. Cogn Behav Neurol 16:170-176